Issue 123 • October 2022Nanorobots: small solutions to big delivery problems Brazil: an untapped market for big pharma manufacturingForeign investments amplify the nucleic acid therapeutics fieldIn association withExploring the promise of billion-dollar KRAS drugsKRAS mutations are one of the most prevalent drivers of cancer, yet they were long considered ‘undruggable’; a new wave of drugs is changing thatIn association withIssue 122Brought to you by02/24/2024 01:17:30